Donor-Derived Second Generation of CD19 CAR-T Cell Therapy for Relapsed B-Cell Acute Lymphoblastic Leukemia after Allogenic Stem Cell Transplantation | |
Zhang, Rongli; He, Yi; Yang, Donglin; Wang, Ying; Feng, Sizhou; Wang, Jianxiang; Han, Ming-Zhe | |
2018 | |
卷号 | 132 |
关键词 | donor-derived CD19 CAR-T cell therapy allogenic stem cell transplantation B cell acute lymphoblastic leukemia relapse |
ISSN号 | 0006-4971 |
DOI | 10.1182/blood-2018-99-114950 |
URL标识 | 查看原文 |
收录类别 | SCIE |
内容类型 | 期刊论文 |
URI标识 | http://www.corc.org.cn/handle/1471x/6348982 |
专题 | 中国医学科学院 北京协和医学院 |
推荐引用方式 GB/T 7714 | Zhang, Rongli,He, Yi,Yang, Donglin,et al. Donor-Derived Second Generation of CD19 CAR-T Cell Therapy for Relapsed B-Cell Acute Lymphoblastic Leukemia after Allogenic Stem Cell Transplantation[J],2018,132. |
APA | Zhang, Rongli.,He, Yi.,Yang, Donglin.,Wang, Ying.,Feng, Sizhou.,...&Han, Ming-Zhe.(2018).Donor-Derived Second Generation of CD19 CAR-T Cell Therapy for Relapsed B-Cell Acute Lymphoblastic Leukemia after Allogenic Stem Cell Transplantation.,132. |
MLA | Zhang, Rongli,et al."Donor-Derived Second Generation of CD19 CAR-T Cell Therapy for Relapsed B-Cell Acute Lymphoblastic Leukemia after Allogenic Stem Cell Transplantation".132(2018). |
个性服务 |
查看访问统计 |
相关权益政策 |
暂无数据 |
收藏/分享 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论